India Post News Paper

 Breaking News

Bharat Biotech, Thomas Jefferson varsity to work on Covid vaccine

Bharat Biotech, Thomas Jefferson varsity to work on Covid vaccine
May 20
15:59 2020

HYDERABAD: Leading vaccine maker Bharat Biotech on Wednesday announced that it has signed an exclusive deal with Thomas Jefferson University of Philadelphia to develop a new vaccine candidate for Covid-19 invented at Jefferson.

The novel vaccine was developed using an existing deactivated rabies vaccine as a vehicle for coronavirus proteins. This is in part because this vehicle or carrier vaccine is known to produce a strong immune response, and is approved for the whole population including children and pregnant women, Bharat Biotech said in a statement.

Infectious Diseases expert Professor Matthias Schnell’s lab developed the vaccine in January this year, and has recently completed preliminary tests in animal models.

The vaccine showed a strong antibody response in mice receiving the vaccine. The researchers are currently testing whether vaccinated animals are protected from SARS-CoV-2 infection with results expected the next month.

“Our partnership with Bharat Biotech will accelerate our vaccine candidate through the next phases of development,” says Prof Schnell – a coronavirus expert who directs The Jefferson Vaccine Institute and chairs Jefferson’s Department of Microbiology and Immunology.

“We are particularly excited about this technology since the basic proof of concept has been established while using it for other pandemic infectious diseases. Bharat Biotech is committed to global public health and will be involved in an end to end development of the vaccine including comprehensive clinical trials to achieve commercial licensure,” said Dr Krishna Mohan, Chief Executive Officer of Bharat Biotech.

Under the license agreement, Bharat Biotech gains exclusive rights to develop, market and deliver Jefferson’s vaccine across the world excluding countries such as USA, Europe, Japan etc, where Jefferson continues to seek partners.

With support from the Department of Biotechnology, Government of India, Bharat Biotech aims to get into human trials as soon as December 2020.

Of the 90 or so coronavirus vaccines in development, about 25 per cent use an established vaccine to act as a carrier or vector for the target virus, in this case, the coronavirus SARS-COV-2 spike protein.

“Since we know the immune system reacts to the rabies vaccine with a strong response when we add the coronavirus component, we expect to see that level of protection, and immune memory, carry over to the SARS-CoV-2 viral protein as well,” says Prof Schnell.

Comments

comments

Related Articles

    COVID 19 – GLOBAL CASES


    Enter your email address:

    Delivered by FeedBurner

    E-paper Latest Edition

    ADVERTISEMENT – DAFABET ESPORTS

    Dafabet Gaming Portal

    ADVERTISEMENT – NRIA NET

    www.nria.net

    ADVERTISEMENT – DR HORTON

    Dr Horton Skyline Ridge

    ADVERTISEMENT – SEVEN JACKPOTS

    casino

    ADVERTISEMENT – BETRALLY INDIA

    betting India

    ADVERTISEMENT – DR HORTON

    ADVERTISEMENT – Star Tours

    Star Tours

    50 SPIRITUAL APPETIZERS – VINOD DHAWAN

    50-ad-Indiapost

    It’s a lovely book. It feels energetically clear and light. It’s easy to read, dip in and out and most importantly it offers information without fluff! Blessings on this project.

    Jac O’Keeffe
    Spirituality teacher based in USA.

    *Available on Amazon, Flipkart & other online stores*

    ADVERTISEMENT – JOBSORA- FIND A JOB NOW!

    Jobsora Jobs

    Follow us On Twitter

    Sagar Ratna files police complaint against rumour-monger - https://t.co/Mh7ChJjE4h Get your news featured use… https://t.co/xfyGJakOmR
    h J R
    Domestic flights take-off, but ... - https://t.co/Ttn8rVorWF Get your news featured use #IndiaPostUSA #AirIndia… https://t.co/wJN2z5MRRH
    h J R
    #India an attractive #Investment destination: ... - https://t.co/zVdxAEx7eg Get your news featured use… https://t.co/EHiA1lN1Ik
    h J R
    WHO appreciates China's openness ... - https://t.co/FFFztvDMkZ Get your news featured use #IndiaPostUSA… https://t.co/32bAqlQVov
    h J R

    POPULAR CATEGORIES

    Download Media Kit

    India Post Media Kit